VEGF-mediated blood-brain barrier disruption is thought to exacerbate inflammation in TB meningitis [41] and in vitro induction of VEGF production in human monocytic THP-1 cells by Mtb sonicate or culture supernatant could be completely abrogated by corticosteroid treatment. This evidence concerns the gene VEGFA and meningeal tuberculosis.